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ABSTRACT 
Tuberculosis (TB) is a major public health problem worldwide, and particularly in South 
Africa. Micronutrient deficiency (malnutrition) is caused by insufficient supply of 
vitamins and minerals for normal cell function in the body. Nutritional deficiencies in 
minerals, vitamins and diets rich in carbohydrates have been implicated in the 
pathogenesis of oral candidal infections. Malnutrition and wasting are associated with 
TB, and HIV/TB co-infection may potentially worsen the wasting that occurs in TB or 
HIV infection alone. Aim of the study was to investigate the relationship between 
micronutrient deficiency and Oral Candidiasis (OC) in adult TB patients. The prevalence 
of OC and its association with malnutrition in terms of Zinc (Zn), Iron (Fe), Albumin, 
Selenium (Se),Vitamin A (Vit A) and Vitamin D (Vit D) deficiencies were evaluated in a 
cross sectional study among eighty eight (n=88) TB adult patients. Patients underwent a 
complete oral examination for presence and type of OC and blood collection was done 
for serum nutritional assessment for levels of the micronutrients (Zn, Fe, Albumin, Se, 
Vit A and Vit D). Results: The mean age was 36 years of age, with the majority being 
females (60%) and HIV positive (69.3%). The prevalence of OC was 60% with 
pseudomembranous OC (48%) being the most common. Serum concentrations for Zn 
deficiency (< 8.2 µmol/L) was 69.4%, Vit A deficiency (< 1.05 µmol/L) was 52.3%, 
Albumin deficiency (< 35 g/L) was 69%, Se deficiency (< 46 µg/L) was 93.2%, Fe 
deficiency (< 9 µmol/L) was 53.7% and Vit D deficiency (< 49 nmol/L) was 45.1%. OC 
was prevalent in 40% (Zn deficiency), 25% (Vit A deficiency), 32% (Albumin 
deficiency), 33% (Se deficiency), 31% (Fe deficiency) and 36% (Vit D deficiency). 
However, there was no significant association between micronutrient deficiency and OC 
(p > 0.05). Conclusion: These data demonstrate that OC in TB adult patients is not 
associated with micronutrient malnutrition. Longitudinal studies are required to 
investigate the relationship between micronutrient deficiency and OC in adult TB patients 
further. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Background 
Mycobacterium tuberculosis (M. tuberculosis) is the most widespread bacterial pathogen 
in the world, infecting close to one-third of the human population (Raviglione, 2003). 
Approximately two million people across the world succumb to tuberculosis (TB) every 
year (Smith, 2003).  
 
Tuberculosis (TB) is a major public health problem in South Africa (SA). South Africa is 
ranked fifth on the list of 22 high burden TB countries in the world. According to the 
World Health Organization (WHO, 2009), there were an estimated 460 000 new TB 
cases in SA in 2007, with the incidence rate of 948 cases per 100 000 population. The 
control of TB is jeopardised by the Human Immunodeficiency Virus (HIV) and Acquired 
Immune Deficiency Syndrome (AIDS) as one-third of 40 million people living with 
HIV/AIDS (PLWA) are also infected with M. tuberculosis (Tovaru et al., 2008).  
Despite SA’s investments in TB control, progress toward reaching programme objectives 
has been slow. Treatment increased from 65% in 2001 to 74% in 2006, but is still lower 
than other African countries that have high HIV/AIDS prevalence rates with fewer 
resources. Multidrug resistant (MDR) TB, as a result of non-adherence to drug regimens 
and/or inappropriate drug regimens, further worsens the epidemic. The prevalence of 
MDR TB has tripled, from 2 000 cases in 2005 to 7 350 in 2007. From 2007 there has 
also been an increase of extreme drug resistant (XDR) TB cases, from 74 in 2004 to 536 
in 2007 (SA National Department of Health Report, 2009).  
In SA, TB is associated with poverty, overcrowding, alcoholism, stress, drug addiction 
and malnutrition (Nutrition Information Centre of the University of Stellenbosch 
[NICUS, 2007]). An important component of malnutrition is “micronutrient deficiency”, 
which refers to the lack of sufficient micronutrients such as vitamins, iron and zinc in an 
individual. Lack of micronutrients in foods can lead to low energy levels, low immunity 
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and higher rates of disability and chronic illness among affected populations. Those most 
at risk are children, pregnant and breastfeeding mothers, and PLWA and/or TB (Woods 
et al., 1999). 
Patients who have HIV/AIDS, TB and pneumonia have opportunistic infections, such as 
oral candidiasis (OC) [Saha et al., 2011]. Oral candidiasis is one of the common 
opportunistic infections of the oral cavity that can involve the hard and soft palate, 
tongue, buccal mucosa and floor of the mouth. It is caused by the overgrowth or infection 
of the oral cavity by yeast-like fungus from the candida species (Scully, 1990). The main 
species are C albicans (most common), C tropicalis, C glabrata, C pseudotropicalis, C 
guillierimondii, C krusei, C lusitaniae, C parapsilosis, and C stellatoidea. The most 
common OC oral lesions are pseudomembranous, eythematous and angular cheilitis 
(Reichart, 2003). Previous studies have shown an association between OC and 
micronutrient deficiency in individuals that have been infected with TB. However, the 
prevalence of OC in TB and TB/HIV co-infected cases is worthy of further investigation 
and research, particularly regarding micronutrient deficiency in these patients, since there 
are very few studies demonstrating this association. 
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CHAPTER 2: LITERATURE REVIEW 
 
Multiple bibliographic databases, including EBCOhost, PUBMED, WEB OF SCIENCE 
and Goggle Scholar, were used to develop a comprehensive review of the literature on 
OC and micronutrient deficiency in TB patients. The databases were searched for 
publications related to this topic until August 2011. Selected keywords included TB, 
HIV/AIDS and TB patients, micronutrient deficiency, social habits, oral candidiasis. 
2.1 Tuberculosis 
Tuberculosis is an infectious disease caused by the bacilli micro-organism called 
Mycobacterium tuberculosis (M. tuberculosis), which usually enters the body by 
inhalation through the lungs. It spreads from the lungs to other parts of the body via the 
blood stream, the lymphatic system, the airways, or by direct extension to other organs. 
The most common form of TB is pulmonary TB, but it can also occur in the lymph 
nodes, kidneys, bones and oral cavity. The symptoms of pulmonary TB are chest pain 
and severe cough with blood in the sputum, exhaustion, night sweats, fever, loss of 
appetite and weight loss (NICUS, 2007). 
M. tuberculosis has the ability to enter into a dormant state, leading to an asymptomatic 
infection that persists for years. Approximately 95% of individuals that are exposed to M. 
tuberculosis remain asymptomatic; the remaining 5% develop TB which is localised in 
the lungs (Tovaru et al., 2008). In addition to the weakening of the immune system due to 
a debilitating disease, malnutrition or advancing age may result in the reactivation of the 
latent bacilli.  
M. tuberculosis infects all parts of the mouth (soft and hard palate, uvula, buccal mucosa, 
gingivae, lips, tongue, maxilla, and mandible) more often in men than in women, 
appearing mainly in the form of ulcerative lesions (Kakisis et al., 2010).  
2.2 HIV in SA 
By 2009 an estimated 5, 6 million people were living with HIV in SA (more than in any 
other country) and 310 000 people in the country were reported to have died of AIDS 
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(UNAIDS, 2010). In the same year almost one-in-three women aged 25 to 29, and over a 
quarter of men aged 30 to 34 were living with HIV (Shisana et al., 2009). The TB and 
HIV epidemics stimulate each other in several ways. HIV-infected patients have the 
greatest risk of developing TB and if this is left untreated it leads to death within months 
in 90% of those co-infected with TB/HIV (Corbett et al., 2003). People living with HIV 
are particularly vulnerable to XDR TB because of their increased susceptibility to 
infection through nosocominal transmission, malabsorption of TB medication, acquired 
Rifampicin resistance and poor response to TB therapy (Dye et al., 2003). 
2.3 Malnutrition, TB and HIV Co-infection 
Micronutrients are substances (vitamins and minerals) required for normal cell function 
in the body. Micronutrient deficiency (malnutrition) occurs because the supply of 
vitamins and minerals to cells in the body is insufficient to satisfy physiological 
requirements. There is a complex three-way relationship between micronutrient 
deficiency, the immune system and infection. Malnutrition elicits immune system 
dysfunctions, which in turn promote increased vulnerability of the host to infection, with 
the latter intensifying the severity of malnutrition (Enwonwu, 2006). Malnutrition alters 
all defence mechanisms, including anatomic barriers, cell-mediated immune responses, 
phagocytic cell/microbial functions and humoral immunity function (antibody and 
complement responses) among many others (Biesel, 1996; Chandra, 1999). Malnutrition 
and wasting are associated with TB, and co-infection with HIV/TB may potentially 
exacerbate the wasting that occurs in TB or HIV infection alone (Niyongabo et al., 1999). 
In the developing world, the impact of TB on nutritional status is worse. A number of 
studies have demonstrated the effect of TB on nutritional status; for example, nutritional 
status was significantly lower in patients with TB than in healthy controls in studies 
conducted in Indonesia, India and Japan (Karyadi et al., 2002). A study conducted in 
Malawi reported a significant reduction in weight, muscle mass, functional subcutaneous 
fat and serum albumin in TB patients (Harries et al., 1988). Tuberculosis/Human 
Immunodeficiency Virus co-infection introduces a new dimension on the pathogenesis of 
nutritional status. Paton et al. (1997) compared wasting in HIV-positive individuals with 
or without TB co-infection in Brazil, and reported that the severity of fat and lean 
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depletion was striking, although the severity of muscle loss in the HIV group was 
underestimated owing to the tendency of extracellular water increase in HIV-infected 
individuals. A study found that wasting and high viral load in pulmonary TB cases is 
indicated by low Body Mass Index (BMI) and plasma micronutrient concentrations (van 
Lettow et al., 2004).  
Micronutrient deficiencies have been reported in individuals with TB (Karyadi et al., 
2002) and in those with HIV infection alone (Semba et al., 1999). Nutritional deficiencies 
of vitamin (Vit) B12, Zinc (Zn) and Selenium (Se) in malnourished people living with 
HIV/AIDS are associated with decreased immune indices and higher risk for disease 
progression (UNAIDS, 2010). Malnutrition weakens immunity, increasing the chance 
that latent TB will develop into active disease. Reduced micronutrient intake (Vit A, C & 
E and Se & Zn) has been associated with impaired immunity (Health System Trust, 
2009). Evidence from several cross-sectional studies suggests that patients with TB are at 
high risk for deficiencies of Vit A, Thiamine, Vit B6, folate, Vit E, and Zn (van Lettow et 
al., 2004). Evidence suggests that Vit D deficiency causes deficient monocyte-
macrophage function and may predispose towards vulnerability to TB (Chan, 1997). A 
higher incidence of TB during the winter or early spring was seen in the former Ciskei 
(Shennan, 1993), South Africa (Schaaf, 1996) and Bashkortostan in Russia (Iakovlev, 
1994), suggesting an increased transmission of TB infection in autumn and winter. 
Selenium (Se) deficiency has been shown to increase the risk of developing 
mycobacterial disease among HIV-infected drug users as Se plays an important role in 
the selenoenzyme glutathione peroxidise that protects cells against free radical damage 
and oxidase stress (Shor-Posner et al., 2002). Koyanagi et al. (2004) reported that patients 
with pulmonary TB had low serum concentrations of Vit A, Zn and Se compared to non-
TB patients. 
The influence of HIV on nutritional status results in a complex series of reactions, i.e. 
fever, production of specific acute–phase proteins, release of inflammatory mediators, 
anorexia, proliferation of the immune cells, endothelial cell activation and other 
metabolic changes (Baumann, 1994). Consequently nutrients (e.g. Fe, copper, Se and Zn) 
are simultaneously compartmentalised to the tissues, lost from the body or blocked from 
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cellular utilisation (Gabbay and Kushner, 1999). HIV infection affects the nutritional 
status through a reduction in food intake, resulting in the loss of appetite, an increase in 
the side effects of medication, mouth lesions and depression (Enwonwu, 2006). Other 
causes of malnutrition in HIV-infected individuals are nutrient malabsorption (e.g. 
malabsorption of fats, fat-soluble vitamins and carbohydrates) and the metabolic changes 
which promote increased utilisation of nutrients, particularly micronutrients and 
antioxidants (Friis et al., 1998; Semba et al., 1999). 
2.4 Nutritional Deficiencies and Oral Mucosa Diseases 
Oral manifestations of nutritional deficiency include nonspecific signs and symptoms that 
involve the mucous membranes, the teeth, the periodontal tissues, the salivary glands and 
the perioral skin (Thomas et al., 2010). Activities such as eating, drinking and breathing 
affect mucous membrane that is weakened by deficiencies. In addition, the local 
microenvironment of the mouth is non-sterile to commensal and pathological 
microorganisms that may further stress the weakened mucous membrane (Boyd, 2007).  
Not all vitamins and minerals affect the oral mucosa. Water-soluble vitamins that have 
oral mucosal involvement include vitamins B2, B3, B6, B12, folic acid and Vit C. Fat-
soluble vitamins that affect the mucosa include Vit A, D, E, and minerals relevant to the 
oral mucosa are calcium, fluoride, Fe and Zn (Thomas et al., 2010). Vit A is responsible 
for producing photosensitive pigments, maintaining epithelial tissue, preventing 
infectious diseases and growth, and modelling bones and tissues (Boyd, 2007; Krall et al., 
2007). The oral manifestations of Vit A deficiency include xerostomia, reduced 
resistance to infections and impaired growth of the teeth. Vit A can be stored in the body 
reaching toxic levels, with oral manifestations such as cheilitis, gingivitis, carotenemia 
and impaired healing (Palmer and Boyd, 2009). Vit D deficiency may increase the 
likelihood of periodontitis (Boyd, 2007) and Vit E deficiency may be associated with oral 
cancer (Thomas et al., 2010) 
Iron is important for different normal functions of the body, i.e. as part of haemoglobin, 
which plays an important role in oxygen transport, adesone triphosphate production and 
normal immune function, and is a cofactor with Vit C in collagen production (Boyd, 
2007; Palmer and Boyd., 2009). The oral manifestation of Fe deficiency includes atrophy 
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of the lingual papillae, burning and redness of the tongue, angular cheilitis, dysphagia, 
recurrent aphthous ulcers and pallor of the oral tissues due to underlying anaemia (Palmer 
and Boyd, 2009).  
Zinc plays a variety of critical roles in the cell, particularly acting as an enzymatic 
cofactor critical for cell growth and reproduction, normal immune function, metabolism, 
and as a stabiliser of DNA and RNA and collagen synthesis (Boyd, 2007). Pregnant 
women, diabetics, those infected with HIV/AIDS, the elderly, those with sickle cell 
anaemia (Thomas et al., 2010) and those with TB (Lin et al., 2000) are at high risk of Zn 
deficiency. Oral manifestations of Zn deficiencies include changes to the epithelium of 
the tongue, flattened filiform papillae, ulcers and xerostomia (Boyd et al., 2001; Palmer 
and Boyd, 2009). It also decreases the taste sensation, which can cyclically contribute to 
the malnutrition problem (Krall et al., 2007; Palmer and Boyd, 2009).    
2.5 The Oral Cavity and Oral Candidiasis 
The oral cavity is a habitat of potential pathogens, i.e. fungal, bacterial and viral, which 
can multiply and cause disease in immunosuppressed patients. Most of the organisms 
associated with oral opportunistic infections are either part of the normal flora or 
common in the environment and likely to pass through the mouth. Oral pathogens and 
their toxins can spread to other tissues and organs directly (e.g. necrotising gingivitis and 
periodontitis spreading to cause some degree of necrosis of the soft tissue (Ibeziako et al., 
2003) and OC to pharyngeal and oesophageal candidiasis) and indirectly via lymphatics 
and the blood stream and possibly even to the central nervous system (Johnson et al., 
2006). 
Candida spp. resides as commensal organisms in the normal oral, vaginal and stomach 
flora. If the balance in the normal flora is disrupted or the immune responses are 
compromised, the Candida spp. becomes pathogenic, causing mucosal disease (Naglik et 
al., 2011).  
OC has been has been identified as one of the oral lesions strongly associated with 
HIV/AIDS (EC-Clearinghouse, 1993) and it is a marker of immune suppression (Miziara 
et al., 2006). OC associated with HIV infection occurs frequently and could be 
considered as an initial manifestation of the disease (Pienaar et al., 2010). OC has been 
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reported in 50 to95% of all HIV-positive persons at some point during their progression 
to full-blown AIDS (Gupta et al., 2006). Opportunistic infections and co-infections are 
common among HIV-infected individuals, especially in individuals with a low CD4 
count. A cohort study conducted by Holmes et al. (2006) in Cape Town found that 
opportunistic infections among HIV-infected individuals increased significantly at lower 
CD4 cell (50 cells/ µL or less). These opportunistic infections included conditions such 
as TB, bacterial infections, chronic diarrhoea, OC and oesophageal candidiasis, wasting 
syndrome, and cryptococcal disease. Also in this study, TB and OC occurred commonly 
with CD4 counts of more than 200 cells/ µL and were the only opportunistic infections to 
occur in CD4 counts of more than 500 cells/ µL. 
A longitudinal study conducted in Kolkata (India) by Saha et al. (2011) found that 
opportunistic infections and co-infections that were common among HIV-infected 
individuals were TB, chronic diarrhoea, OC, herpes simplex virus-2 (HSV-2), 
cytomegalovirus (CMV), hepatitis B virus (HBV) and hepatitis C virus (HCV). The most 
common dual infections were chronic diarrhoea (CD) and OC (28.29%), OC and TB 
(25.94%), CD with TB (21.08%), HSV-2 and OC (19.11%), HSV-2 and CMV (14.21%), 
HBV and HSV-2 (3.92%), HBV and CMV (2.94%), the least common being HCV and 
HBV(0.49%). The most common triple infections were OC, TB and CD (8.34%) and 
HSV-2, CMV and CD (8.34%).  
2.6 OC and Micronutrient Deficiencies 
Micronutrient deficiencies of Fe, folic acid, Vit A, B, C, K and Zn, and a carbohydrate-
rich diet have a significant impact on the pathogenesis of OC infection (Samaranayake, 
1986). Studies in relation to OC associated with micronutrient deficiencies in adult TB 
cases are limited. A study conducted by Paillaud et al. (2004) found that OC is related to 
malnutrition and that mucosal lesions have a negative impact on energy intake, which 
subsequently worsens the nutritional status in institutionalised elderly people. In 
individuals with nutritional Vit B12 deficiency, the oral signs and symptoms include 
glossitis, angular cheilitis, recurrent oral ulcers, OC, diffuse erythematous mucositis and 
pale oral mucosa, which offer the dentist an opportunity to participate in the diagnosis of 
the condition (Pontes et al., 2009). 
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There is a paucity of studies that have investigated the relationship between OC and 
micronutrient malnutrition in adults with TB and TB/HIV co-infection. The findings of 
this study will be helpful in identifying subgroups that will benefit from nutritional 
interventions for reducing the prevalence of OC and micronutrient malnutrition in adult 
TB patients.  
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Aims and Objectives of the Study 
AIM 
The aim of the study was to investigate the relationship between micronutrient deficiency 
and Oral Candidiasis (OC) in adult TB patients, in Alexandra, Johannesburg (JHB). 
OBJECTIVES 
1. To describe the demographics and HIV status among a cohort of adult TB patients 
between 18 and 60 years of age.  
2. To determine the prevalence of OC among the TB cohort. 
3. To investigate the association between OC and micronutrient status among TB 
patients.     
HYPOTHESIS 
There is a significant association between OC and micronutrient deficiency amongst 
adult TB patients. 
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CHAPTER 3: METHODOLOGY 
 
This chapter describes the research methodology used to conduct this study. The methods, 
ethical considerations and analytic techniques pertaining to this study are also dealt with 
in this chapter. 
3.1 Study Design 
The study adopted a cross-sectional, analytical study design. A questionnaire was 
designed to establish the age, gender and HIV status of the sample population. Clinical 
oral examination was carried out to assess the presence of OC, and blood samples were 
collected for serum analysis of micronutrient levels of Se, Albumin, Vit A, Vit D, Fe and 
Zn. 
3.2 Study Population  
This research was part of a bigger study called the “Nutritional Indicator Research 
Survey” (NIRS) (Ethics clearance certificate: M090955) that evaluated the impact of 
fortified food (e-pap) on the nutritional status of adult TB patients over a three-month 
period. The methodology adopted in the current research and described below was 
derived from the NIRS study (see Appendix G).  
3.3 Study Sample 
A convenient sampling technique was employed to recruit patients into this study. The 
NIRS researchers contacted South African National Tuberculosis Association (SANTA) 
and requested them to identify Johannesburg (Joburg) clinics in Alexandra that provided 
TB outpatients with treatment and support. Permission was obtained from the Joburg City 
Department of Health and the Gauteng Department of Health and Social Development 
(GDHSD). A copy of the permission letter is attached as Appendix F. 
Four JHB clinics were identified and two with the highest number of TB patients were 
selected. Thus , two clinics were selected as research sites. The total sample size screened 
and recruited for the NIRS was 120. Oral examination and blood specimens were 
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collected in only 88 participants as 32 of the recruited participants were not present on 
the day of examination and blood sample collection. Thus, this study is based on a 
sample size of 88 adult TB patients. 
3.4 Study Instruments 
The study instruments consisted of the following components. 
3.4.1 Demographics 
A questionnaire referred to as a “personal record sheet” was developed to obtain the 
demographic data, such as age, race and gender, of the participants (see Appendix A). A 
primary health care (PHC) nurse completed the personal record sheet with the patient and 
recorded the HIV status of each participant from their clinical records.  
3.4.2 Two clinical instruments 
3.4.2.1 Oral examination for OC 
Oral examination was conducted by a calibrated dentist and dental therapist. The 
inter-examiners’ agreement was assessed using the kappa statistic, with an overall 
value of 0.80 – 0.95 for the diagnosis of OC. The patients were examined at the 
research site, seated on mobile dental chairs and under head lamp and light, using 
disposable hand mirrors. The diagnosis of the clinical variants of OC was made in 
accordance with the criteria developed by Sharon and Fazel (2010) and is described 
below: 
a. Pseudomembranous Candidiasis was characterised by the presence of 
extensive white pseudo-membranes consisting of desquamated epithelial cells, 
fibrin and fungal hyphae.  
b. Erythematous Candidiasis was characterised as erythematous patches that 
appear bright red and that can be found intraorally.  
c. Angular Cheilitis was characterised as erythematous fissuring at one or both 
corners of the mouth, associated with an intraoral candidial infection.  
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Patients were also asked if they experienced any burning mouth or sore tongue or lip. The 
presence of lower and upper dentures was also recorded.  
3.4.2.2 Laboratory component: serum biochemical analysis for micronutrient levels 
The micronutrient analysis for the serum levels of Se, Zn, Fe, Vit A, Vit D and Albumin 
were conducted by the National Health Laboratory Services (NHLS), under the 
supervision of staff from Department of Biochemical Pathology. These nutrients were 
selected because of their key roles in supporting immune function and quenching free 
radicals (Rudolph et al., 2011). Patients were considered to be micronutrient deficient if 
one or more of the following micronutrients’ serum levels were below the normal range 
as shown in Table 1. The normal micronutrient levels’ criteria outlined in Table 1 are 
used by the NHLS, based on the clinical guide developed by Alan (1995).  
Table 1: Individual micronutrient serum analysis (*Alan, 1995) 
Micronutrient *Normal Range Cut Off Levels 
Zinc 8.2-23 µmol/L  < 8.2 µmol/L 
Vitamin A 1.05-2.80 µmol/L < 1.05 µmol/L 
Albumin 35-52 g/L < 35 g/L 
Selenium 46-143 µg/L < 46 µg/L 
Iron 9-31 µmol/L 
(Male: 11.6-31.3 µmol/L) 
(Female: 9-30.4 µmol/L) 
< 9 µmol/L (male and 
female) 
Vitamin D 49 -172 nmol/L < 49 nmol/L 
 
The micronutrient levels were analysed individually, as outlined in Table 1. The 
micronutrient levels were reported as group prevalences (percentage normal versus 
percentage below normal) in this cohort and the relationship between each individual 
micronutrient deficiency and the prevalence of OC was analysed to determine if there 
was a significant association (p < 0.05).  
3.5 Data and Statistical Analysis  
STATA 11 software was used for all statistical analysis. All statistical significance was 
calculated at the 5% significance level. 
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3.5.1 Data checking and cleaning 
Range checks for outliers were carried out using histograms, and box and whisker plots 
for continuous variables. Consistency checks to identify inconsistencies in the data were 
undertaken using scatter plots. 
3.5.2 Independent variables  
Micronutrient deficiency and demographic profile (Age and gender)  
 
3.5.3 Dependent variables  
Oral Candidiasis 
3.5.4  Analysis by objective 
Objective 1: To describe the demographics social and HIV status of adult TB 
patients.  
The study population variables were described using frequency tables for categorical 
variables and continuous variables, and were summarised in terms of mean and standard 
deviation, median and inter-quartile range. 
Objective 2: To determine the prevalence of OC amongst the TB cohort. 
The proportion of patients with oral candidiasis was determined using frequency tables 
and the prevalence of different types of oral candidiasis was reported using pie charts. 
Objective 3: To investigate the association between OC and micronutrient status 
among TB patients 
The associations between categorical variables and OC were tested using Pearson’s Chi-
squared test of proportions. The Fischer exact test was used for variables that had an 
expected frequency of five or less. Continuous variables were described using histograms 
and normal quantile plots. Normally distributed continuous variables were tested for their 
association with OC using the Student’s t test. Non-normal continuous variables were 
tested using the Wilcoxon rank-sum test. Logistic regression was used to identify factors 
which were associated with a presence of OC. The odd ratios were used to determine the 
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strength of the association. The statistical significance was calculated at the 5% 
significance level and estimates were reported at the 95% confidence interval. 
3.6 Ethics  
The NIRS received ethical clearance from the University of Witwatersrand Ethics 
Committee (Ethics clearance certificate: M090955) to conduct the study and collect 
blood samples from the TB patients. Permission to undertake the current study was also 
granted by the University of Witwatersrand Ethics Committee (Ethics clearance 
certificate: M10733, see Appendix E). Each participant was given an information sheet 
(see Appendix C) and a written consent form for obtaining their permission to participate 
in the study (see Appendix D), which they had to sign. For illiterate participants the 
researcher explained the purpose of the study to obtain their consent. All adults diagnosed 
with oral candidiasis or any oral lesions were referred to their local dental clinic in 
Alexandra for treatment. 
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CHAPTER 4: RESULTS 
4.1 Demographics 
Table 2 below shows that the mean age of the total sample (n=88) was 36.7 years (S.D. 
9.97). The majority of TB patients were women (60.2%) and most were unemployed 
(74%). Almost 70% of TB patients in this cohort were HIV positive.  
Table 2: Overall characteristics of TB patients (n=88) 
Demographics 
 
Age in years Median (IQR)         36   (28 – 42) 
 
Mean (Std Deviation)   36.66 (9.97)   
 
 N % 
Sex  
Female 
Male 
 
53     
35     
 
60.2 
39.8 
Employment  
Yes 
No 
 
23      
65      
 
26.1 
73.9 
HIV Status  
Negative 
Positive 
 
27        
61      
 
30.7 
69.3 
 
4.2 Micronutrient Deficiency Levels 
Table 3 provides information about the mean blood serum levels of the micronutrients 
investigated in this study. Although the sample size was 88, not all blood results were 
available for the micronutrient analysis, hence the number’s per micronutrient is different 
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often less than 88. The mean values of most of the micronutrient (Zn, Vit A, Se, Fe, and 
Albumin) levels were above the normal ranges for these micronutrients except for Vit D, 
which had a mean level that was below the normal range (47.96 nmol/L; S.D. 17.91). 
This was also indicated by 54.9% of the sample who had Vit D deficiency. 
Table 3: Individual micronutrient deficiency of TB patients (n=88) 
Micronutrients N                % Median(IQR) 
Mean (Std 
Deviation) 
Zn n = 49 
 
    
No (> 8.2 µmol/L)  
 
34 69.39  
 
10.05 (7.4 – 
11.1) 
 
 
 
10.60 (4.66) Yes (< 8.2 µmol/L)  
 
15 30.61 
Vit A n = 65     
No  
(> 1.05 µmol/L) 
 
34         
          
 
       52.31 
        
 
1.05 (0.74 – 
1.46) 
 
 
1.13 (0.43) 
Yes 
(< 1.05 µmol/L) 
 
31         
       
 
       47.69 
           
Se n = 44 
 
 
 
 
 
  
No (> 46 µg/L) 41         
  
      93.18 
         
 
68 (58 – 83) 
 
 
 
 
 
 
69.12 (17.41) 
Yes (< 46 µg/L)    3                    6.82 
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Micronutrients 
 
N 
             
   % 
 
Median(IQR) 
 
Mean (Std 
Deviation) 
Fe n = 67 
 
 
 
 
  
 
10.1 (6.6 – 
15.8) 
 
 
 
11.19 (6.59) 
No (> 9 µmol/L) 
 
 
36        
 
53.73 
Yes (< 9 µmol/L) 
 
31         
     46.27 
  
Albumin n= 67 
  
    
No (> 35 g/L)  46        68.66 
 
 
38 (33 – 41) 
 
 
37.28 (5.55) 
 Yes (< 35 g/L)  
 
21        31.34 
Vit D n= 51     
No 
( >49 nmol/L) 
 
 
23          
 
    45.10 
 
 
46.35 (36.13 – 
60.23) 
 
 
47.96 (17.91) 
 
 Yes 
(< 49 nmol/L) 
 
 
28          
 
       54.90 
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Table 4 provides information of the mean blood serum levels of the micronutrients 
investigated in the TB/HIV co-infected cases (n=61; 70%). The mean values of all the 
micronutrient (Zn, Vit A, Se, Fe, Albumin and Vit D) levels were above the normal 
ranges of these micronutrients. 
Table 4: Individual micronutrient deficiency of TB/HIV co-infected patients (n=61) 
Micronutrients N                % Median(IQR) 
Mean (Std 
Deviation) 
Zn n = 35 
 
    
No (> 8.2 µmol/L)  
 
15 43  
 
10.00 (6.2– 
11.00) 
 
 
 
9.60 (5.82) Yes (< 8.2 µmol/L)  
 
20 57 
Vit A n = 28     
No  
(> 1.05 µmol/L) 
 
17         
          
 
       60.71 
        
 
1.00 (0.82 – 
1.32) 
 
 
1.08 (0.68) 
Yes 
(< 1.05 µmol/L) 
 
11         
       
 
       39.28 
           
Se n = 36 
 
 
 
 
 
  
No (> 46 µg/L) 23         
  
     64 
         
 
 
 
62 (55-73) 
 
 
 
67.15 (13.28) 
Yes (< 46 µg/L)   13                   36  
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Micronutrients N                % Median(IQR) 
Mean (Std 
Deviation) 
Fe n = 36 
 
 
 
 
  
 
9.63 (7.8 – 
13.8) 
 
 
 
10.6 (7.2) 
No (> 9 µmol/L) 
 
 
  15      
 
41.66 
Yes (< 9 µmol/L) 
 
   21      
     58 
  
Albumin n= 37 
  
    
No (> 35 g/L)  23        62 
 
 
39 (31-39) 
 
 
38.42 (4.62) 
 Yes (< 35 g/L)  
 
14        38 
Vit D n= 46     
No 
(> 49 nmol/L) 
 
 
17          
 
    37 
 
 
44.28 (34.22 – 
61.48) 
 
 
49.46 (19.84) 
 
 Yes 
(< 49 nmol/L) 
 
 
29         
 
       63 
 
4.3 Prevalence of OC among TB patients (n=88) 
Of the 88 TB patients, 40% (n=35) had OC and 60% (n=57) did not have OC present 
(Figure 1). In terms of prevalence of OC by clinical type, Figure 2 shows that 48% (17) 
of the TB patients had pseudomembranous, 28% (10) had erythematous, 14% (5) had 
angular cheilitis and 10% (3) had hyperplastic. 
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Figure 1: Overall Oral Candidiasis prevalence (n=88)
40%
n=35
60%
n= 53
No Oral Candidiasis Oral Candidiasis
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Figure 2: Prevalence of Oral Candidiasis by clinical type (n=35)
28%
n=10
14%
n=5
10%
n=3
48%
n=17
Pseudomembranous OC Erythematous OC
Angular Cheilitis Hyperplastic OC
 
4.4 Association between OC and Demographics, HIV Status and 
Micronutrient Deficiency  
The relationship between OC, demographics, HIV status and micronutrient deficiency 
was determined by the Pearson chi-squared (Fisher exact) test for categorical variables.  
The Wilcoxon rank-sum test for non-normal continuous variables and Student’s t test for 
normally distributed continuous variables (e.g. age) were used.  
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4.4.1 Demographics and OC 
Table 5 below shows the median age for patients with OC was 38 and the mean age was 
37; there was no statistically significant relationship between OC and age. The 
prevalence of OC was higher among the females (39.62%) than among males (28.57%), 
although this was not statistically significant (p=0.288). Employed subjects had a slightly 
higher prevalence of OC (37.70%) than those unemployed (34.78%; p=0.805). Thirty-
five per cent of TB/HIV co-infected patients had OC compared to 37% of TB patients. 
There was no statistically significant relationship between OC and any of the 
demographics discussed below.  
Table 5: Associations between oral candidiasis and demographics 
Demographics No OC OC Present *p value 
Age in years  
Median(IQR) 
Mean (Std Deviation) 
 
35.5 (28 – 42) 
36.5  (10.21) 
 
38 (31 – 44) 
37.35 (9.47) 
 
 
0.702 
Sex (n, %) 
Female 
Male 
 
32             60.38 
25             71.43 
 
21          39.62 
10          28.57 
 
 
0.288 
Employment (n, %) 
No 
Yes 
 
15            65.22 
38            62.30 
 
8            34.78 
24         27.27 
 
 
0.805 
HIV Status (n, %) 
 
Negative (TB only) 
Positive (TB/HIV co-infection) 
 
 
17            19.36 
37               42.0 
 
 
10           11.4  
24           27.3 
 
0.524 
 
*p value for Student’s t test for normally distributed continuous variables (e.g. Age), Wilcoxon rank-sum test for non-
normal continuous variables and Pearson’s Chi squared test for categorical variables, Fisher’s exact test for categorical 
variables with n < 5 per cell. 
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4.4.2 Association between OC and micronutrient deficiency 
For subjects with OC micronutrient levels below the normal range were present among 
40% (6) of Zn, 25% (8) of Vit A, 33% (1) of Se, 32% (10) of Fe, 32% (7) of Albumin 
and 36% (10) of Vit D respectively. For TB patients with OC micronutrient levels within 
the normal range were present among 23% (8) for Zn, 47% (16) for Vit A, 26% (11) for 
Se, 38% (14) for Fe, 36% (17) for Albumin and 17% (4) for Vit D respectively. OC was 
not significantly associated with lower levels of micronutrients when compared to normal 
micronutrient levels in TB patients who had no OC (Table 6).   
Table 6: Associations between oral candidiasis and micronutrient deficiency 
Micronutrient 
Deficiency 
No OC OC Present *p value 
Zinc  
 
N % N %  
 
 
 
0.216 
  No (> 8.2 µmol/L)  
 
 
27 77 8 23 
Yes (< 8.2 µmol/L)  9 60 6 40 
Median (IQR) 10.05 (8.2-11.1) 9.6 (6.8-12.9) 0.705 
Mean  
(Std Deviation) 
10.33 (3.25) 11.3 (7.24) 
Vitamin A  
 
     
 
 
0.063 
No (> 1.05 µmol/L) 18 53 16 47 
Yes(< 1.05 µmol/L) 24 75 8 25 
Median (IQR) 0.99 (0.69-1.32) 1.21 (0.99-1.58) 0.182 
Mean (Std Deviation) 1.07 (0.45) 1.22 (0.39) 
Selenium       
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No(> 46 µg/L) 31 74 11 26 1.000 
Yes(< 46 µg/L) 2 67 1 33 
Median (IQR) 68 (58-83) 65 (58.5-78.5) 0.739 
Mean (Std Deviation) 69.65 (17.94) 67.67 (16.57) 
Iron Deficiency  
 
     
 
 
 
No (> 9 µmol/L)  23 62 14 38 0.567 
Yes (< 9 µmol/L)  22 69 10 31 
Median (IQR) 9.5 (6.9-15.2) 10.1(6.05-17) 0.816 
Mean( Std Deviation) 11.33 (6.96) 10.94(5.98) 
Albumin       
 
 
0.728 
No (> 35 g/L)  
 
30 64 14 36  
Yes (< 35 g/L) 
 
15 68 7 32 0.728 
Median (IQR) 37 (34-41) 39 (31.5-40.5) 0.978 
Mean (Std Deviation) 37.29 (5.69) 37.25 (5.37) 
Vitamin D 
 
     
 
0.210 
No 
(> 49 nmol/L) 
 
19 83 4 17 0.210 
Yes 18 64 10 36 
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(< 49 nmol/L) 
 
Median (IQR) 48.83 (36.13-
60.23) 
43.39 (35.81-64.58) 0.739 
Mean (Std Deviation) 48.45 (17.47) 46.57 (19.67) 
*p value for Wilcoxon rank-sum test for non-normal continuous variables and Pearson’s Chi squared test for 
categorical variables, Fisher’s exact test for categorical variables with n < 5 per cell. 
4.5 Predictor Variables for OC among TB patients  
There was no significant association between gender, employment status, HIV status, 
micronutrient level and the presence of OC (Table 7). The strength of these associations 
was weak (p > 0.05) and suggests that the demographic variables and micronutrient levels 
are not good predictors of the presence of OC in TB patients.  
Table 7: The odds ratio between demographics, micronutrient levels and OC 
Demographics Odds Ratio 
95% Confidence 
Interval 
*p value 
Age in years  1.01 0.97 – 1.05 0.698 
Sex 
Female 
Male 
 
1  
0.61 
 
 
0.24 – 1.52 
 
 
0.284 
Employment 
No 
Yes 
 
1  
1.13 
 
 
0.42 – 3.09 
 
 
0.804 
HIV Status 
Negative 
Positive 
 
1  
1.12 
 
0.44 – 3.44 
 
 
0.845 
Zinc Deficiency  
No (> 8.2 µmol/L) 
Yes (< 8.2 µmol/L) 
 
1  
2.25 
 
 
0.61 – 8.25 
 
 
0.221 
Vitamin A Deficiency  
No (> 1.05 µmol/L) 
 
1 
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Yes (< 1.05 µmol/L) 0.37 0.13 – 1.07 0.066 
Selenium Deficiency  
No (> 46 µg/L) 
Yes (< 46 µg/L) 
 
1 
1 1.41 
 
 
0.12 – 17.11 
 
 
0.788 
Iron Deficiency  
No (> 9 µmol/L) 
Yes (< 9 µmol/L) 
 
1  
0.75 
 
 
0.27 – 2.03 
 
 
0.567 
Albumin Deficiency  
No (> 35 g/L) 
Yes (< 35 g/L) 
 
1 
1 0.82 
 
 
0.28 – 2.41 
 
 
0.724 
Vitamin D Deficiency 
 
No (> 49 nmol/L) 
Yes (< 49 nmol/L) 
 
 
 
 
 
1 
2.25 
 
 
 
0.61 – 8.25 
 
 
 
0.221 
 
There was no significant association between TB/HIV co-infection, micronutrient level 
and the presence of OC. The strength of these associations was weak (p > 0.05) and 
suggests that micronutrient levels are not good predictors of the presence of OC in 
TB/HIV co-infected patients (Table 8). 
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Table 8: The odds ratio between micronutrient deficiency and OC in TB/HIV co-
infected (n=61) 
Micronutrient 
levels 
Odds Ratio 
95% Confidence 
Interval 
*p value 
Zinc  
(< 8.2 µmol/L) 
& OC 
2.25 1.9-2.4 0.22 
Vitamin A  
(< 1.05 µmol/L) 
& OC 
1.5 1.2-1.8 1.02 
Selenium  
(< 46 µg/L) & 
OC 
1.4 0.95-1.5 1.00 
Iron  
(< 9 µmol/L) & 
OC 
0.75 0.55-1.2 0.57 
Albumin  
(< 35 g/L) & 
OC)  
0.8 0.45-1.3 0.73 
Vitamin D  
(< 49 nmol/L) 
& OC  
 
2.63 2.45-3.00 0.20 
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CHAPTER 5: Discussion and Conclusion  
 
This study aimed to determine the relationship between micronutrient deficiency and OC 
among adults with TB. The demographic profile of the TB cohorts was determined. In 
addition an oral examination was conducted to determine the presence of OC and blood 
serum levels of the micronutrients (i.e. Zn, Vit A, Se, Fe, Albumin and Vit D), which 
were analysed by the NHLS.  
5.1 Demographic Profile 
The mean age in this TB cohort was 36, 7 years; the majority of whom were females 
(60%) and unemployed (73, 9%). This is in contrast to general population statistics, 
which show that approximately twice as many males as females are diagnosed with TB in 
SA and developing countries each year (Dolin, 1998; Holmes et al., 1998). Austin et al.’s 
(2004) retrospective study of secondary data analysis from the laboratory register of the 
SA Institute of Medical Research also reported that male TB patients outnumbered 
females TB patients at a ratio of 2.08:1 in the Western Cape. The higher percentage of 
females in the TB cohort might be due to the fact that more females are HIV positive and 
more likely to be compliant in attending clinics for TB treatment and recall visits than 
males (Lertmaharit et al., 2005). Brennan et al. (2010) reported that females tend to 
utilise public health services more often than males do. Although the study sample is not 
representative of all TB patients in SA, it is indeed worrying that fewer males (who are 
the majority of people infected with TB) than females were regular attendees at these 
clinics as indicated by the clinic register (Rudolph et al., 2011).   
Approximately 70% of the TB cohort in the current study was HIV positive. However, 
John et al. (2007) reported a 90% rate of TB/HIV co-infected patients admitted to the 
medical ward in Helen Joseph Hospital. This finding could be due to Helen Joseph in-
patients having more co-existing conditions than outpatients do.  
The present study did not explore HIV prevalence by gender. However, the NIRS (2011) 
using the same sample reported that more females (76%) were HIV positive than males 
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24% (Rudolph et al., 2011). In SA (SA NDoH, 2009) and sub-Saharan Africa nearly 60% 
of those living with HIV/AIDS are females (Prah, 2004). This higher percentage is not 
unexpected because females are generally at higher risk for HIV infection as they are 
biologically, socially and culturally more HIV susceptible than men (Darnton–Hill et al., 
2005).  
5.2 TB or HIV/TB Co-infection and Micronutrient Deficiency Levels 
The link between TB and malnutrition consists of two interactions: the effect of TB upon 
nutritional state and the effect of malnutrition on the occurrence and clinical 
manifestations of TB (Macallan, 1999). Consequently in TB cases, nutrients (e.g. Fe, 
Copper, Se and Zn) are simultaneously compartmentalised to the tissues, lost from the 
body or blocked from cellular utilisation (Enwonwu, 2006). 
5.2.1 Zinc 
Several studies have demonstrated that the serum levels of Zn decreased significantly 
during active TB and increased following recovery after institution of antitubercular 
therapy and improvement of nutritional status (Wiid et al., 2004; Milano et al., 2004). In 
the present study, 30% of the sample had mean serum levels of 10.60 (S.D. 4.66) µmol/L 
for Zn deficiency. This prevalence was significantly lower than that reported by 
Koyanagi et al. (2004), who reported Zn deficiency in 61% of the TB cases [10.01 (S.D. 
1.88) µmol/L].  A study investigating the relationship between wasting and micronutrient 
malnutrition in 222 TB patients and 579 TB/HIV co-infected patients conducted by van 
Lettow et al. (2004) also reported that TB patients are at a higher risk of Zn deficiency 
with prevalence as high as 85%. The large percentage differences in the findings between 
this TB cohort and the reported studies is due to the differences in the cut off levels of 
defining Zn deficiency [current study < 8.2 µmol/L; Koyanagi et al., (2004) < 10.7 
µmol/L; van Lettow et al., (2004) <11.5 µmol/L]. 
Tuberculosis/Human Immunodeficiency co-infection worsens Zn deficiency in patients 
as it is shown in the current study that 57% of the TB/HIV co-infected patients had Zn 
deficiency at a mean value of 9.60 (S.D. 5.82) µmol/L. Studies have shown Zn deficiency 
to be more prevalent in TB/HIV co-infected cases versus TB only controls (van Lettow et 
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al., 2004). A study conducted by Kassu et al. (2006) to evaluate the serum levels of 
copper, Zn, Se and Fe in TB patients with or without HIV reported that the concentration 
of Zn in 74 of the TB/HIV co-infected patients (mean 73.65, S.D. 37.66 µg/dl) was 
significantly lower (p<0.05) than that in 81 of the TB patients without HIV co-infection 
(mean 81.14, S.D. 14.16 µg/dl) and (mean 88.85, S.D. 34.16 µg/dl ) in 31 of the healthy 
controls (no TB or HIV infection) [p<0.001]. The difference between the TB cohort in 
this study and the cohort of the reported study by Kassu et al. (2006) is related to the cut 
off levels and units defining Zn deficiency; however, it is worth noting that the level of 
Zn in patients that are TB/HIV co-infected is very low, indicating strong association of 
hypozincaemia with impaired immune response and degree of malnutrition as reported 
previously from HIV-positive and AIDS patients (Graham et al., 1991). 
5.2.2 Vitamin A 
Slightly more than half of this sample (52%) had Vit A deficiency (< 1.05 µmol/L), with 
a mean of 1.13 (S.D. 0.43) µmol/L. This compares favourably with Koyanagi et al. 
(2004), who found 52% of 46 pulmonary TB cases and 10 controls (non-TB cases) who 
had a serum concentration of Vit A below 1.05 µmol/L.  Koyanagi et al. (2004) also 
reported that there was a significantly lower mean Vit A in the TB cases [1.16 (S.D. 0.65) 
µmol/L] versus in the non-TB controls [2.80 (S.D. 0.83) µmol/L]. However, Karyadi et 
al. (2002), in a randomised control trial investigating whether Vit A and Zn 
supplementation increases the efficacy of anti-tuberculosis treatment with respect to 
clinical response and nutritional status, reported that at baseline 32% of newly diagnosed 
TB patients (n=80) had Vit A deficiency [(<0.70 µmol/L), with a mean of 0.82 (S.D. 
0.04) µmol/L]. The lower percentage of Vit A deficiency in Karyadi et al.’s (2002) study 
is probably because, firstly, the sample consists of newly diagnosed TB patients who 
have never received any anti-tuberculosis intervention and, secondly, that the cut off 
levels defining Vit A deficiency were different from the one used in the current study and 
that of Koyanagi et al. (2004) [current study and Koyanagi et al. (2004) cut off levels (< 
1.05 µmol/L) and Karyadi et al. (2002) (< 0.70 µmol/L)]. 
In this TB cohort, 61% of the TB/HIV co-infected patients had Vit A deficiency [mean 
1.08 (S.D. 0.43) µmol/L] as compared to the 52% of the TB only infected patients. The 
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high proportion of individuals with low Vit A levels in the TB/HIV co-infected subgroup 
cannot be explained by nutritional deficiencies alone. Studies have also shown that low 
Vit A levels are common in patients with TB and those infected with HIV and are even 
more severe among patients with HIV/TB co-infected (Semba, 1997). Mugusi et al., 
(2003) conducted a study that sought to determine serum Vit A levels of 100 HIV-
positive and -negative TB patients and 144 healthy controls and reported that serum Vit 
A levels were lower among HIV-infected individuals [mean 18.8, S.D. 5.7 µg/dl] and 
lowest among TB/HIV co-infected patients [mean 13.1, S.D. 5.6 µg/dl] than controls 
[mean 26.6, S.D. 5.4 µg/dl]. Low levels of Vit A were found to be more common among 
TB patients with a significantly high prevalence among those HIV positive (64, 4%) than 
healthy controls (9.1%) (p< 0.0001). Although this current study did not show any 
significant association between Vit A deficiency and TB or TB/HIV co-infected 
subgroups, it seems that TB/HIV co-infection may potentially worsen Vit A deficiency 
than TB or HIV alone because Vit A deficiency is associated with TB/HIV co-infection 
and more pronounced with HIV disease progression (Baum et al., 2003).  
5.2.3 Selenium 
Selenium has immunopotentiating effects and its deficiency appears to result in 
immunosuppression (Roy et al., 1994). Thus, it reduces the virulence of HIV and slows 
the progression of HIV-related disease (Rayman, 2000). Approximately 7% of the TB 
cohort had Se deficiency (< 46) µg/L) with a mean of 69.12 (S.D. 17.41) µg/L. Koyanagi 
et al. (2004) conducted a study that compared the serum concentrations of Zn, copper, Se, 
Vit A and Vit E among 46 pulmonary TB cases  with of 10 healthy controls (non-TB 
cases). This study reported a significantly lower Se concentration in pulmonary TB cases 
than in the healthy controls [1.81 (S.D. 0.25) versus 1.99 (S.D. 0.23) μmol/L]. The 
difference in the current study and Koyanagi et al.’s (2004) findings is due to the 
difference in the cut off levels and units defining Se deficiency [current study (46 µg/L) 
and Koyanagi et al. (2004) (1.81 μmol/L)].  
Koyanagi et al. (2004) also reported only three HIV/TB cases 6.52% as compared to an 
estimated 70% of the current study sample being co-infected with TB/HIV. In the 70% of 
the TB/HIV co-infected cases in this study, 36% had Se deficiency [mean 67.15 (S.D. 
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13.28) µg/L], compared to the only 7% of TB only infected cases with Se deficiency. An 
inverse correlation between Se and HIV infection was reported by Dworkin (1994), who 
conducted a study to determine plasma Se concentration in 12 patients with AIDS 
compared to five healthy controls. He reported that plasma Se in AIDS patients was 
significantly lower than in the healthy controls [mean 0.043 (S.D. 0.01) microgram/ml 
versus mean 0.095 (S.D. 0.016) microgram/ml (P < 0.001)] and that patients with AIDS 
tend to have more severe Se deficiency than those with earlier stages of HIV infection. 
There is a lack of a standardised definition of micronutrient deficiency for some 
micronutrients such as such as Se (cut off levels and units), making it difficult to achieve 
a valid comparison between the current study and the reported studies as illustrated above 
[current study Se deficiency < 46 µg/L, Koyanagi et al. (2004) < 1.81 μmol/L and 
Dworkin (1994) < 0.53 micrograms/g. Never the less , the current study and other 
reported studies indicate that those with TB/HIV co-infection are susceptible to lower 
concentrations of Se as compared to TB only infected cases or healthy controls (non-TB). 
Furthermore, Kassu et al.’s (2006) study aimed to determine serum levels of 
micronutrient (Zn, copper, Se, calcium and magnesium) in 375 pregnant (42 HIV 
positive) and 76 non-pregnant women (20 HIV positive) who visited the University of 
Gondar Hospital in Ethiopia. Kassu et al. (2006) reported that the mean serum level of Se 
was significantly lower in pregnant women with HIV co-infection compared to HIV-
negative pregnant women (p < 0.05). This study differs from the current study in terms of 
study sample size (n=88 versus n=375) and the type of sample (HIV-positive and -
negative pregnant women, as pregnant women were excluded from the current study). 
5.2.4 Iron 
Iron deficiency prevalence varies according to age, gender, physiological, pathological 
and socioeconomic conditions (WHO, 2001) and it is more prevalent in infants, children, 
pregnant women and people of low socioeconomic status (Gibson, 2005). There was an 
Fe deficiency (< 9 µmol/L) in 46.3% of this TB cohort [mean 11.19 (S.D. 6.59) µmol/L] 
and in 58% of the TB/HIV co-infected cohort, with no significant association between Fe 
deficiency and TB or TB/HIV co-infection [mean 10.6 (S.D. 7.2) µmol/L]. However, 
Kassu et al.’s (2006) study, which compared serum levels of Fe, copper, Zn and Se 
0711805m 
 46 
 
among 81 TB only infected cases, 74 TB/HIV co-infected cases and 31 healthy controls 
(non-TB and HIV negative) and investigated changes in serum levels of these 
micronutrients before and after an intensive phase of anti-TB chemotherapy in the TB 
only infected cases and TB/HIV co-infected cases, reported a significant difference of Fe 
deficiency (<60 µg/dl) between TB/HIV co-infected patients [mean 14 (S.D 18.9)] µg/dl 
and healthy controls [mean 1 (S.D. 3.2)] µg/dl (p < 0.01). There was also Fe deficiency 
(< 60 µg/dl) in the TB patients without HIV co-infection [mean 9 (S.D. 11.1)] µg/dl 
versus healthy controls [mean 1(S.D. 3.2)] µg/dl, but the difference was not statistically 
significant (p < 0.07). The difference between the current study and that of Kassu et al. 
(2006) is that different cut off levels and units to define Fe deficiency were used in the 
two studies. Taha and Thanoon (2010) also reported that serum Fe values were 
significantly lower in pulmonary TB cases in comparison with controls. Although the 
current study did not find a significant association between Fe deficiency and TB only 
infected cases and TB/HIV co-infected cases, studies have shown that severe Fe 
deficiency in TB/HIV co-infected cases is directly linked to HIV infection, as HIV-
positive cases experience reduction in food intake (Enwonwu, 2006) and nutrient 
malabsorption (Friss et al., 1998), making those individuals co-infected with TB/HIV 
more vulnerable to Fe deficiency.  
5.2.5 Albumin 
Albumin deficiency was found in 31% of the TB cases, with a mean value of 37.28 (S.D. 
5.55) g/L, and in 38% of the TB/HIV co-infected cases, with a mean value of 38.42 (S.D. 
4.62), with no significant association between Albumin deficiency and TB. Although 
Ramakrishnan et al. (2008) reported significantly lower serum levels of Albumin in 
TB/HIV co-infected cases (mean 2.9, S.D. 0.4 g/dL) than in TB cases (mean 3.6, S.D. 0.7 
g/dL). In their study participants had to fast before blood collection for micronutrient 
analysis, while in the current study patients were provided with food during the data and 
blood collection phase. The units are different between the two studies but the means are 
similar, as 3.6 g/dL in the TB cases is equivalent to 36 g/L, although there is a slight 
difference in the S.D. between the two studies. Mugusi et al. (2003) also reported that the 
mean serum Albumin was significantly lower in HIV-positive [mean 29.7, S.D. 7.6 
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µmol/l] than in HIV-negative patients [mean 31.4, S.D. 8.1 µmol/l].  However, Okamura 
et al. (2011) further investigated the relationship between hypoalbuminemia and 
computed tomography findings of the lungs, and reported that hypoalbuminemia [mean 
value of 3.3 (S.D. 0.71) g/dL] was significantly related to the presence of typical 
radiographic findings of TB in patients of over 70 years of age.   
5.2.6 Vitamin D 
Fifty-five per cent of the TB cohort in the current study had Vit D deficiency, with a 
mean of 47,96 (S.D. 17.91) nmol/L; however, a case control study by Ho-Pham et al. 
(2010) that sought to determine the association between Vit D deficiency (< 30 ng/mL), 
parathyroid hormone and the risk of TB in a Vietnamese population of 166 TB cases (113 
men and 53 women) and 219 non-TB healthy controls (113 men and 106 women) 
reported that the prevalence of Vit D insufficiency was 35.4% in men with TB and 19.5% 
in controls (p = 0.01). In women, there were no significant differences in Vit D between 
TB patients (n=53) and controls (n=106). The prevalence of Vit D insufficiency in 
women with TB (45.3%) was not significantly different from those without TB (47.6%; p 
= 0.91).  
The difference between the findings of the current study and that of Ho-Pham et al. 
(2010) could be due to differences in the TB sample size (n=166) versus the 88 TB 
sample size of the current study. There is also a difference in the cut off levels that define 
Vit D deficiency (current study 49 nmol/L and Ho-Pham et al. (2010) 30 ng/mL). The 
prevalence of Vit D deficiency was higher in the TB/HIV co-infected (63%), with a mean 
value of 49.46 (S.D. 19.84), with no significant association between TB/HIV co-infection 
and Vit D deficiency. Nansera et al.’s (2011) study, which measured Vit D and calcium 
levels in 50 HIV-negative, 50 HIV-infected and 50 TB/HIV co-infected Ugandan adults, 
also reported mean and standard deviation Vit D levels of 26 (S.D.7 ng/ml) in HIV-
negative, 28 (S.D. 11 ng/ml) in HIV-infected and 24 (S.D. 11 ng/ml) in TB/HIV co-
infected adults (p > 0.05 all comparisons). Also Vit D deficiency (<12 ng/ml) was absent 
in the HIV-negative controls and present in 10% of the HIV-positive and in 12% of those 
TB/HIV co-infected (p = 0.03 HIV negative versus p > 0.05 TB/HIV co-infected cases). 
Suboptimal Vit D levels (< 20 ng/ml) were noted in 20% of the healthy controls, 22% of 
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the HIV-positive subjects and 38% of the TB/HIV co-infected subjects (p = 0.047 healthy 
vs TB/HIV co-infected cases p > 0.05). Individuals with TB/HIV co-infection usually 
have severe micronutrient malnutrition due to a combination of TB infection and high 
viral load. 
5.3 OC and Demographics 
A bivariate analysis was conducted using the Pearson Chi-squared and Fischer exact tests 
to determine the association between OC, demographics, HIV status and micronutrient 
deficiency.  
5.3.1 OC, demographics and HIV status 
Forty per cent (n=35) of the TB cohort had OC, with pseudomembranous OC being the 
most prevalent (48%). OC was more prevalent in females and in those above the mean 
age of 37, with no significant association between age, gender and OC.  Ikebe et al. 
(2006) also reported that candidal activity was not significantly associated with age or 
gender in the relatively healthy individuals of above 60 years of age, as certain systemic 
conditions (e.g. diabetes mellitus), defects of the immune system (Zaremba et al., 2003; 
Coleman et al., 1993; Jacob et al., 1998), and /or some medications (e.g. antibiotics, 
corticosteroids) may predispose the transformation of colonisation of species such as 
Candida into opportunistic pathogens (Webb et al., 1998) .    
In addition OC was more prevalent in the HIV-positive (27, 3%) cases than in HIV-
negative individuals. This finding is in line with the findings of Akpan et al. (2002), who 
reported that OC was more prevalent in HIV-positive individuals, as 95% of HIV-
positive individuals had OC when compared to HIV-negative individuals in the reported 
study. In the majority of HIV-positive patients OC is often present as an initial 
manifestation of HIV infection (Pienaar et al., 2010), and is a useful clinical marker of 
patients with high viral load (Campro et al., 2002). Therefore, even though only 27.3% of 
the HIV-positive cases in the current study had OC, evidence has shown that OC is one 
of the key opportunistic infections that occur commonly and that it recurs frequently in 
HIV-positive cases.   
0711805m 
 49 
 
5.3.2 OC and micronutrient deficiency 
The oral cavity is a reservoir of different potential pathogens, bacterial, viral and fungal, 
which can multiply and cause disease in malnourished and immunocompromised patients. 
Only a few studies have investigated factors such as Zn, Albumin, Se, Fe, Vit A and D 
and their possible role in the alteration of oral mucosal integrity (e.g. Samaranayake, 
1986). Thus, it was also difficult to make a comparison of the current findings with other 
studies for the association between micronutrient deficiency and OC as illustrated below 
(especially in relation to Vit A, Albumin and Vit D) . 
5.3.2.1 Zinc 
In the present study, 40% of the TB patients had OC and Zn deficiency (< 8.2 µmol/L) 
and    23% had OC within Zn levels the normal range (> 8.2 µmol/L) .However, there 
was no significant association between OC and Zn deficiency. In contrast , Paillaud et 
al.’s (2004) case control study comparing OC cases and no OC controls reported that 
44% of hospitalised elderly patients (> 70 years of age) had Zn deficiency (< 12·5 
µmol/L), with a significant association between OC and Zn deficiency. An estimated 
70% of the current sample was co-infected with TB/HIV and Baum et al. (2003) reported 
Zn deficiency (< 0.73 µg/mL) in 56% of HIV-positive drug users, with a mean of 
0.73µg/mL, and fasting blood samples were collected from the participants. Baum et al.’s 
(2003) sample (drug users) and Zn deficiency definition are different from those used in 
the current study, resulting in differences in the results. However, it is important to note 
that Zn deficiency has been linked to a declining CD4 count in HIV-positive individuals 
because it reduces the generation of T cells and depresses humoral and cell-mediated 
immunity; thus, Zn supplements are important in Zn-deficient HIV/AIDS patients even 
among those being administered HAART (Beach et al., 1992). 
5.3.2.2 Iron 
OC was present in both, patients with Fe deficiency (31% at < 9 µmol/L) and with Fe 
levels within the normal range (38% at > 9 µmol/L). There was no significant difference 
between those with high Fe and OC compared to those with low Fe levels. Walker et al. 
(1972) also could not find any differences in the frequency of OC or oral carriage rate of 
0711805m 
 50 
 
Candida in Fe-deficient subjects and controls, and there was no significant change in the 
disease process observed after Fe replacement therapy. Similarly, Samaranayake and 
Macflare (1981) identified five Fe-deficient patients with chronic atrophic OC in whom 
adequate restoration of serum Fe levels had no effect on the recurrence of OC. In 
addition, Jenkins et al. (1977) could not establish a relationship between Fe deficiency 
and chronic atrophic or hyperplasic variety of OC. Recurrent OC infection in normal Fe 
levels could be due to systemic diseases, such as diabetes mellitus, and dentures.  
However, Paillaud et al. (2004) reported OC in hospitalised patients of above 70 years of 
age with an Fe level of below < 40 µmol/L, with 13% experiencing OC and 24% not 
experiencing OC. In addition Fletcher et al. (1975) reported a high prevalence of OC in 
Fe-deficient patients who had angular cheilitis and atrophic glossitis. The difference in 
the findings may be due to the difference in the demographics of the population (age and 
hospitalised) and the study design. Also institutionalisation per se may render elderly 
individuals vulnerable to nutritional deficiency (Schorah et al., 1979; Marazzi et al., 
1990) because the storage of foods and the cooking procedures used in institutions may 
contribute to the loss of vitamins from the food. Hospitalised elderly TB patients also 
have limited food choice, which ultimately affects their food intake and micronutrient 
serum levels as compared to TB outpatients. There is also a high prevalence of 
edentulousness in elderly patients, which limits their food choice and impacts negatively 
on their micronutrient status (Sheiham et al., 2001) as compared to the TB cohort dentate 
sample (100% of the population had more than 20 teeth in their mouth). Also none of the 
sample for the current study had dentures while the sample used in Sheiham study had 
dentures, as dentures and old age are a high risk to OC, which probably explains Paillaud 
et al.’s (2004) findings.  
5.3.2.3 Selenium 
OC was present both in patients with Se deficiency (33% at < 46 µg/L) and in patients 
with Se levels within the normal range (26% at < 46 µg/L), with no significant difference 
between OC and Se levels. Even though the current study did not analyse the viral loads 
in the TB/HIV co-infected cases, Dworkin (1994) reported significantly lower Se levels 
in AIDS cases (mean 0.043, S.D. 0.01 microgram/ml vs mean 0.095, S.D. 0.016 
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microgram/ml) than in controls. This occurred in both homosexuals and drug users with 
AIDS and irrespective of the presence or absence of diarrhoea or gastrointestinal 
malabsorption. Selenium deficiency is common in HIV-positive patients, indicated by 
low plasma and red blood cell levels of Se, and diminished activity of glutathione 
peroxidase, and AIDS patients tend to have more severe deficits than those with earlier 
stages of HIV infection (Dworkin, 1994). The differences in the findings between 
Dworkin’s study and the current study could be the result of Dworkin’s (1994) 
homosexual and drug user sample, which had a high viral load as compared to the TB 
outpatient sample.  
5.3.2.4 Vit A, Albumin and Vit D 
In the present study, OC was present both in patients with micronutrients below the 
normal range [Vit A (25%), Albumin (32%) and Vit D (36%)] and in patients with 
micronutrient levels within the normal range [Vit A (47%), Albumin (36%) and Vit D 
(17%)]. However, there was no significant difference between OC and these 
micronutrient levels, and there is a lack of studies that have investigated the relationship 
between these micronutrients (Vit A, Albumin and Vit D) and OC in a TB cohort. 
However, Steenkamp et al.’s (2009) study conducted in Mangaung in children (one to 10 
years of age) reported a median Albumin level of 32 g/l (IQR 28; 35) in 78% of the 
sample. An estimated 63% of the children had Vit A deficiency at a median of 18.15 
(IQR 15.3; 22.35) µg/dl and 44% for Vit D deficiency at a median of 20 (IQR 16; 24.5) 
ng/ml. Children with abnormally low Vit A levels presented with significantly higher 
viral loads and lower CD4 cell counts. 
There are differences between the current study and Steenkamp et al.’s (2009) study in 
terms of the sample, recording and analysis of the viral load and CD 4 cell count, and 
analysis of the micronutrients in combination. However, Steenkamp et al. (2009) 
indicated that the negative impact HIV has on these micronutrient deficiencies and OC 
has been identified as one of the oral lesions strongly associated with HIV/AIDS (EC-
Clearinghouse, 1993) and is a marker of immune suppression (Miziara et al., 2006). OC 
associated with HIV infection occurs frequently and could be considered as an initial 
manifestation of the disease (Pienaar et al., 2010). Although the current study shows no 
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significant association between OC and Vit D, Vit A and Albumin deficiency, there is 
evidence that 70% HIV-positive patients are likely to have experienced OC and/or Vit D, 
Vit A and Albumin deficiency (Kassu et al., 2006). 
It is important to note that there are other different host factors which are independently 
implicated in the development of OC; these factors include old age, treatment with 
antibiotics, denture wearing and neglected oral hygiene, all of which predispose patients 
to the occurrence of OC (Shay et al., 1997).  
5.4 Limitations and Future Directions 
This study had a few limitations worthy of mentioning, namely the small sample size of 
TB patients and the lack of a control group, which restricted the ability to draw 
conclusions about the associations between the independent and dependent variables. 
Future studies will benefit from much larger sample sizes to draw more convincing 
conclusions. This study is, however, a useful starting point for understanding the 
association between micronutrient deficiency and OC in TB patients. More case control 
studies are needed to investigate the association of micronutrient deficiency and OC in 
TB cases versus non-TB cases.  
5.5 Conclusion 
The present study shows that there is a high prevalence of OC, especially 
pseudomembranous OC as well as high prevalence of several micronutrient deficiencies 
among adult TB patients. Yet there was no association between micronutrient deficiency 
and OC in adult TB patients. Further longitudinal investigations with larger samples are 
needed for determining whether micronutrient deficiencies are an independent risk factor 
for OC. 
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APPENDIX A: Personal Record Sheet  
 
Reference # 
 
Date (dd/mm/yy)  
Gender  
 Age  
Race  
HIV Status  
(0= HIV-,1=HIV+) 
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APPENDIX B: Oral Candidiasis Status Data Capture 
Sheet 
 
1. Refer no.……………………………………………………….. 
 
 
Oral Candidiais (tick appropriate box): 
 
Present                                                                      Absent 
 
Type of Oral Candidiasis (Clinical diagnosis): 
 
1. Pseudomembranous 
 
    
2. Erythematous         
        
 
3. Angular Cheilitis     
 
Symptoms: (tick appropriate box): 
 
 
a. Burning oral sensation    
 
 
b. Sore Tongue    
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Denture (tick appropriate box): 
a. Present       
 
 
b. Absent 
 
Type of denture (tick appropriate box): 
 
a. Partial  
 
b. Full/Full 
Location of denture (tick appropriate box): 
 
a. Lower  
 
b. Upper 
 
 
 
Location (tick appropriate box): 
 
1. upper lip  
2. lower lip  
3. mucosa of the upper lip  
4. mucosa of the lower lip  
5. mucosa around the corner on R side  
6. mucosa around the corner on L side  
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7. cheek mucosa on R side of patient  
8. cheek mucosa on L side of patient  
9. mucosa of upper jaw, bet lip/cheek & gums  
10. mucosa of lower jaw, bet lip/cheek & gums  
11. mucosa of gums of upper teeth  
12. mucosa of gums of lower teeth  
13. top surface of tongue  
14. sides of tongue  
15. under surface of tongue  
16. mucosa between undersurface of tongue & 
gums of L teeth 
 
17. mucosa of hard palate  
18. mucosa of soft palate  
19. mucosa behind last molar of U & L jaws  
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APPENDIX C: Participant Information Sheet 
Good day  
My name is Dr Maphefo Thekiso. I am a Registrar in the Public Oral Health Division at 
the School of Public Health at the University of Witwatersrand (Wits). I would like to 
invite you to participate in a study I’m conducting entitled “The relationship between 
micronutrient deficiency and Oral Candidiasis among Tuberculosis patients in 
Alexandra, Johannesburg”. 
What is the purpose of the Study? 
The main aim is to investigate the association between certain vitamins and minerals, and 
oral sores - “oral thrush” among TB patients. The information gathered may assist the 
Wits Public Oral Health Division and the South African National Tuberculosis 
Association (SANTA) to understand the relationship between micronutrient deficiency 
and oral candidiasis among Tuberculosis (TB) patients and recommend appropriate 
intervention. 
What the study entails?  
The research process includes the following.  
 Questions about your personal details (i.e. age, gender and social habits).  
 Viewing of clinical records in relation to your HIV status – in full confidentiality. 
 Examination of the mouth will be done using a mirror and light. 
 Blood sample of 10ml will be collected from each participant to measure nutrients 
levels. 
 Blood will be discarded after nutrient analysis and the findings will be kept 
confidential.  
 The collection of blood samples may involve mild discomfort or pain. 
 The blood sample and health status information will be kept confidential as every 
participant will be allocated a reference number. 
 The full examination will take about 15 minutes. 
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If there are any questions you do not wish to answer, you are free not to answer these 
questions.  
Confidentiality: 
All information obtained from you will remain confidential. Only the researcher will 
have access to the data. The information collected will be kept in a secure and locked 
office. You will be given a reference number to maintain anonymity. 
Participation is voluntary: 
Participation is voluntary and you are free not to participate or to respond to any 
questions. Refusal to participate or discontinue will not disadvantage you in any way or 
your treatment. 
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APPENDIX D: Consent Form 
 
Date: ………………………… 
Reference no:.......................... 
 
I have read the information sheet about the study and had it explained to me. I 
understood the purpose of the study. 
I also understand that I have the right to cease participation at any time and to 
refuse answering certain questions. I am told that there will be no risks for me to 
take part or not to take part in the study. 
I understand that my confidentiality will be carefully guarded and no one outside 
the research team will be able to know about my answers, health and oral status. I 
understand that a reference number will be allocated to me to maintain anonymity. 
 
Signature of respondent (If yes)………………………………………………. 
 
Initials of investigator……………………………………………………. 
 
Contact details of main researcher: 
Dr Maphefo Thekiso  
Wits School of Public Health 
Division of Public Oral Health,  
Tel: (011)717-2005,  
Email: maphefo.thekiso@wits.ac.za 
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APPENDIX E: Ethical Clearance  
 
0711805m 
 71 
 
APPENDIX F: Johannesburg City and the Gauteng 
Department of Health and Social Development 
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Appendix G: Executive Summary 
Nutritional Indicator Research Study (NIRS) 
Introduction 
Vitamin and nutrient enriched foods can be vital for individuals suffering from illnesses 
such as TB or HIV, but there is still little evidence demonstrating their efficacy. This 
pilot study sought to begin close this gap. This study will assess the nutritional effects of 
a fortified food product on adults with TB and children in Alexandra, South Africa. The 
study will evaluate the sensitivity and validity of measurement tools to identify 
alternatives to blood analysis to accurately measure individuals’ nutritional status in a 
real world clinical setting. 
 
The Objectives of this study are: 
 
     To record and describe the socio-economic status and the nutritional concerns 
(including food security) of two selected groups recruited from the population of 
Alexandra. 
     To generate baseline data on the nutritional status of these groups; 3-6 year old children 
and adult TB populations in Alexandra, using the following indicators: 
     (1) nutrient intakes 
     (2) blood inflammatory markers and key micronutrient serum levels 
     (3) anthropometric measures of height, weight, waist and hip circumference 
     (4) clinical signs of micro-nutrient deficiency, 
     (5) bio-electrical impedance analysis, 
     (6) skin elasticity, 
     (7) hand-grip strength, and 
     To evaluate the sensitivity and validity of non-invasive indicators of nutritional status 
by correlating these with biochemical serum tests. 
     To evaluate the process and practicality of proposed research instruments and 
procedures. 
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     To develop data-collection skills and build capacity among support staff within the 
community at the research location. 
     To evaluate the impact of a fortified food (e’Pap) on the nutritional status of 
children and adult TB patients over a three (3) month period. 
 
The Investigational Product 
The investigational product (e’Pap) is a fortified food product which includes minerals in 
a chelated, highly bio-available form, and uses processes which preserve essential fatty 
acids and fibre. The formulation is a pre-cooked, multivitamin and mineral fortified, 
wholegrain maize and soya food. It is specially formulated to ensure bio-availability and 
absorption of nutrients. It is widely distributed in South Africa and other African 
countries.   
 
Methodology 
A convenient sample of participants fulfilling the selection criteria listed below will 
drawn from the different site populations. Two sample groups will be selected: adult TB 
patients receiving treatment at local clinics, and children attending creches in Alexandra. 
A total of 120 adults and 65 children will be enrolled in the study.  A broad range of 
nutritional state indicators (Table 1) will be measured on three distinct measurement 
events and recorded on a dedicated set of record sheets. Each participant will be 
monitored at approximately weeks 1, 5, 10 using the full set of evaluation instruments. 
Record sheets will be encoded to ensure anonymity.  
After baseline measurements are recorded, all participants will receive a course of de-
worming medication, then receive the nutritional supplement and will be instructed on 
how to use it. Data will be captured in a database and analysed statistically to determine 
aggregate trends, to detect significant changes in nutritional state, and to evaluate the 
sensitivity and validity of measurement tools. 
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Table 1 (Alan and NHLS , 1995) 
Micronutrient Normal Range 
Zinc 8.2-23 µmol/L  
Vitamin A 1.05-2.800 µmol/L 
Albumin 35-52 g/L 
Selenium 46-143  µmol/L  
Iron 9-31 µmol/L 
(Male:11.6-31.3 µmol/L) 
(Female: 9-30.4 µmol/L)  
Vitamin D 49-172 nmol/L 
 
 Patient Selection Criteria 
1.  Adults 
TB patients receiving treatment from health clinics in Alex will be selected and invited to 
participate based on the following criteria: 
     Inclusion: Adult male and female patients receiving care and TB treatment from a 
clinic in Alexandra. 
     Inclusion: Patients BMI > 16 
     Inclusion: Patients between ages of 18-60 
     Inclusion: Patients consented to participate in the study for its full duration. 
     Inclusion: Patients were outpatients with a history of at least 3 regular visits to the 
clinic. 
     Inclusion: Patients were not regularly consuming e'Pap or a similar fortified food 
supplement. 
     Exclusion: Patients have known food allergies to maize and soya products. 
     Exclusion: Known conditions for which de-worming medication is contra-indicated. 
     Exclusion: Candidates are below critical body weight for blood sample collection (BMI 
< 16) 
     Exclusion: Patients being treated for Multidrug-Resistant TB. 
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                                           2. Children 
Children from creches in Alexandra will be selected according to their fulfilment of 
selection criteria below. Their parents and or guardians will be invited to provide consent 
to allow their children to participate in the research. 
     Inclusion: Children between ages of 3-6 at the time of enrolment 
     Inclusion: Written consent of children’s parents and or legal guardians 
     Inclusion: Regular attendance at selected creches 
     Inclusion: Patients were not regularly consuming e'Pap fortified food supplement. 
     Exclusion: Known food allergies to maize and soya products. 
     Exclusion: Known conditions for which de-worming medication is contra-indicated. 
     Exclusion: Candidates are below critical growth reference for blood sample 
collection (children: MUAC < 110mm) 
 
 
 
  
 
 
 
